Clorox Co. stock (US1890541097): CEO transition news and valuation focus after share-price drop

Clorox Co. shares on the New York Stock Exchange traded lower this week after the company announced a planned leadership change, saying that Chair and Chief Executive Officer Linda Rendle has asked the board to initiate a comprehensive CEO search process as she intends to step down for health reasons, according to a company news release dated 05/28/2026 from Clorox investor relations as of 05/28/2026.

In U.S. trading, Clorox changed hands around USD 92 to 96 per share on 05/29/2026, with MarketBeat data showing a mid-morning price of USD 92.30, down 4.06% on the day, while the previous close was reported at USD 96.19 with a market capitalization of roughly USD 11.6 billion and volume of about 2.0 million shares, according to MarketBeat as of 05/29/2026.

The CEO transition has drawn market attention in the United States, where Clorox is headquartered in Oakland, California and listed on the NYSE under the ticker CLX, and the stock move followed the companys disclosure to the U.S. Securities and Exchange Commission in an 8-K filing that Rendle plans to step aside and a leadership search is underway, as reflected in a summary of the filing dated 05/28/2026 on StockTitan citing the SEC document as of 05/28/2026.

Cloroxs governance update specifies that Rendle will continue to serve as CEO and chair until a successor is appointed, helping to manage the transition period, and the board noted that it has engaged an external search firm to consider both internal and external candidates for the top role, according to the 05/28/2026 company announcement from PR Newswire carrying the Clorox statement as of 05/28/2026.

Market commentary highlighted that U.S. investors reacted to the leadership news with concern, with Investing.com reporting that Clorox stock slid around 3.6% in morning trading on 05/29/2026 after the disclosure about Rendles health-related decision, framing the move within broader worries about execution on the companys turnaround and cost-saving initiatives, as noted by Investing.com as of 05/29/2026.

The stock move leaves Clorox trading near the lower portion of its recent range, as TipRanks data show that over the last 12 months the shares have changed between USD 84.70 and USD 132.03, while the average analyst price target stands at about USD 132.71, according to TipRanks as of 05/29/2026.

The price reaction also comes against a backdrop of a roughly 26% decline in the share price over the past 12 months and a modest negative performance year-to-date, with MarketBeat calculating a 12-month decrease of 26.10% and a year-to-date return of -4.63% for Clorox as of late May 2026, based on MarketBeat as of 05/29/2026.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

Clorox Co.: core business model

Clorox Co. positions itself as a branded consumer products company focused on household cleaning, disinfecting, and everyday essentials across retail and professional channels, with sales concentrated in North America and complemented by selected international operations.

Valuation metrics and multiples for Clorox Co.

The recent share-price decline and the CEO transition have brought valuation metrics for Clorox back into focus, with investors weighing how the companys pricing compares with its earnings profile and relative performance in the U.S. consumer staples space.

According to GuruFocus, Clorox traded at a price-to-earnings ratio of about 15.62 based on its latest reported earnings and share price levels in late May 2026, which the site characterized as a modest valuation compared to some historical averages for the stock, as reported by GuruFocus as of 05/29/2026.

TipRanks data, which aggregate sell-side expectations, point to that average analyst price target of approximately USD 132.71 per share versus a current trading band in the low-to-mid USD 90s, suggesting that the consensus valuation model from covering analysts embeds assumptions for earnings growth and margin stability that are not fully reflected in the latest spot price, according to TipRanks as of 05/29/2026.

MarketBeat figures indicate that the recent pullback has taken Cloroxs market capitalization to around USD 11.6 billion, and when combined with the reported earnings profile, this underpins the mid-teens P/E ratio referenced in third-party valuation commentary, offering a data point for investors comparing Clorox with other U.S.-listed consumer staples names, based on MarketBeat data as of 05/29/2026.

Conclusion

The announcement that Linda Rendle plans to step down as CEO for health reasons and that the Clorox board has opened a CEO search process has become the immediate catalyst for the stocks latest decline on the New York Stock Exchange, with investors digesting the governance implications and transition timeline in the United States market context.

At the same time, valuation metrics such as a mid-teens price-to-earnings ratio and an average analyst target above the current share price provide numerical reference points as market participants reassess Cloroxs risk-reward profile in light of leadership changes, recent share-price weakness, and its positioning within the broader consumer staples sector.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.